Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Capricor Therapeutics (CAPR) Revenue: 2009-2024

Historic Revenue for Capricor Therapeutics (CAPR) over the last 16 years, with Dec 2024 value amounting to $40.0 million.

  • Capricor Therapeutics' Revenue fell 99.70% to $6,740 in Q3 2025 from the same period last year, while for Sep 2025 it was $31.1 million, marking a year-over-year increase of 9.96%. This contributed to the annual value of $40.0 million for FY2024, which is 58.87% up from last year.
  • Capricor Therapeutics' Revenue amounted to $40.0 million in FY2024, which was up 58.87% from $25.2 million recorded in FY2023.
  • In the past 5 years, Capricor Therapeutics' Revenue ranged from a high of $40.0 million in FY2024 and a low of $244,898 during FY2021.
  • In the last 3 years, Capricor Therapeutics' Revenue had a median value of $25.2 million in 2023 and averaged $22.6 million.
  • As far as peak fluctuations go, Capricor Therapeutics' Revenue plummeted by 69.13% in 2020, and later surged by 961.67% in 2022.
  • Capricor Therapeutics' Revenue (Yearly) stood at $310,250 in 2020, then dropped by 21.06% to $244,898 in 2021, then soared by 961.67% to $2.6 million in 2022, then skyrocketed by 868.39% to $25.2 million in 2023, then surged by 58.87% to $40.0 million in 2024.